MDxHealth SA
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.0% | -30.0% | -27.8% | -23.3% | -24.1% | -18.2% | -10.8% | -6.0% | 6.1% | 0.7% | 0.7% | -21.5% | -2.1% | |
| 9.6% | 8.9% | 9.6% | 8.8% | 9.2% | 9.0% | 9.2% | 17.0% | 8.2% | 8.6% | 8.6% | 8.8% | 8.5% | |
| 0.9% | 1.0% | 0.8% | 1.7% | 1.6% | 2.1% | 1.6% | 5.1% | 1.6% | -2.5% | -2.5% | 2.2% | -1.0% | |
| -6.8% | -11.2% | -4.9% | -0.9% | -7.5% | -7.3% | -5.4% | -19.6% | -1.9% | 11.3% | 11.3% | -12.8% | 5.1% | |
| 4.5% | 4.9% | 3.9% | 4.2% | 0.9% | 0.8% | 2.0% | 1.4% | 1.0% | 0.1% | 0.1% | 0.1% | 0.3% | |
| -2.3% | -2.9% | -3.1% | -3.3% | -0.1% | -0.5% | 0.1% | -73.6% | -2.8% | 3.3% | 3.3% | -28.1% | -3.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | -6.3% | -0.3% | 97.0% | -2.5% | -2.0% | -1.4% | 34.2% | -2.6% | 10.2% | |
| -11.7% | -11.8% | -8.8% | 24.2% | 143.9% | 71.7% | 88.4% | -43.9% | -6.1% | -9.4% | -9.4% | -38.4% | -13.7% | |
| -34.9% | -26.7% | -39.8% | 16.3% | 119.8% | -5.1% | 77.7% | -123.5% | -2.9% | -5.5% | -5.5% | -88.0% | -18.7% | |
| -26.6% | -34.9% | -31.7% | -27.5% | -25.0% | -19.0% | -12.8% | -7.4% | 5.1% | 0.6% | 0.6% | -21.6% | -2.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.